Target intelligence / Profile preview

Calcium ion regulation

Molecular classification
Ion channels (e.g., voltage-gated calcium channels, store-operated Calcium channels (Orai1)), Transporters (e.g., sodium/calcium exchangers), Receptors (e.g., calcium-sensing receptor (CaSR)), Enzymes (involved in calcium signaling cascades), Hormones (e.g., parathyroid hormone (PTH), calcitonin, vitamin D)
01

Overview

Calcium ion regulation describes the tightly coordinated, multi-component system responsible for maintaining calcium ion (Ca²⁺) levels in cellular compartments and extracellular fluids. This system includes membrane ion channels (such as voltage-gated and store-operated calcium channels), transporters (such as sodium/calcium exchangers), receptors (especially the calcium-sensing receptor, CaSR), and endocrine regulators (parathyroid hormone, vitamin D, calcitonin)[1][2][3][4][5][7][9]. Calcium ions are essential for muscle contraction, neurotransmission, secretion, gene regulation, and cell survival. Hormonal feedback involving the parathyroid, thyroid, kidneys, and gut maintains calcium homeostasis. Dysregulation causes significant pathologies, including bone fragility, cardiac arrhythmias, and neuropsychiatric symptoms[7][3][6]. In summary, "Calcium ion regulation" refers to a broad system, not a singular protein/receptor, and so does not fit the criteria for a canonical molecular therapeutic target.

02

Mechanism of action

Inhibition or modulation of calcium channels to control influx/efflux (calcium channel blockers); Regulation of calcium absorption and excretion by hormone analogs (vitamin D, calcitonin); Stimulation or inhibition of calcium receptor (CaSR) signaling

03

Biological functions

Signal transductionMuscle contractionNeurotransmitter releaseCell proliferationCell death (apoptosis)Gene expressionHormone secretionBlood clotting
04

Disease associations

Cardiovascular disease (hypertension, arrhythmia)Neurodegenerative diseaseCancer (aberrant calcium signaling linked)Bone disease (osteoporosis, hyperparathyroidism, hypoparathyroidism)Metabolic/inflammatory diseases
05

Safety considerations

Hypocalcemia (muscle spasms, tetany, cardiac arrhythmia)Hypercalcemia (renal stones, bone demineralization, cardiac dysfunction, neurological symptoms)Off-target effects of calcium modulators (e.g., hypotension with calcium channel blockers)
06

Interacting drugs

Calcium channel blockers (e.g., verapamil, nifedipine)

3 more in the full profile.

07

Biomarkers

Serum calcium levelsParathyroid hormone (PTH)CalcitoninVitamin D metabolites

Beyond the preview

Go deeper on Calcium ion regulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium ion regulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call